EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines

Molecular Biology of the Cell

Volumn 22, Issue 18, 2011, Pages 3508-3519

  Minami, Masayoshi ^a   Koyama, Tatsuya ^a,b   Wakayama, Yuki ^a   Fukuhara, Shigetomo ^a   Mochizuki, Naoki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN A1; EPHRIN B1; EPHRIN RECEPTOR A1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAS PROTEIN; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL LINE; DOWN REGULATION; ENZYME INACTIVATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; EPHRINS; GENE KNOCKDOWN TECHNIQUES; IMMUNOGLOBULIN FC FRAGMENTS; INSULIN-LIKE GROWTH FACTOR I; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOBLASTS; MYOSIN HEAVY CHAINS; P120 GTPASE ACTIVATING PROTEIN; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RECEPTOR, EPHA1; RECEPTOR, EPHA2; RNA INTERFERENCE; SEQUENCE DELETION;

EID: 80052838996     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E11-03-0183     Document Type: Article

References (51)

1. Andres V, Walsh K (1996). Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132, 657-666. (Pubitemid 26069245)
2. Bach LA, Salemi R, Leeding KS (1995). Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts. Endocrinology 136, 5061-5069.
3. Bennett AM, Tonks NK (1997). Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278, 1288-1291. (Pubitemid 27495740)
4. Carnac G, Primig M, Kitzmann M, Chafey P, Tuil D, Lamb N, Fernandez A (1998). RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts. Mol Biol Cell 9, 1891-1902. (Pubitemid 28337530)
5. Charrasse S, Comunale F, Fortier M, Portales-Casamar E, Debant A, Gauthier-Rouviere C (2007). M-cadherin activates Rac1 GTPase through the Rho-GEF trio during myoblast fusion. Mol Biol Cell 18, 1734-1743. (Pubitemid 46717555)
6. Charrasse S, Meriane M, Comunale F, Blangy A, Gauthier-Rouviere C (2002). N-cadherin-dependent cell-cell contact regulates Rho GTPases and beta-catenin localization in mouse C2C12 myoblasts. J Cell Biol 158, 953-965. (Pubitemid 35001085)
7. Cheng N, Brantley D, Fang WB, Liu H, Fanslow W, Cerretti DP, Bussell KN, Reith A, Jackson D, Chen J (2003). Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia 5, 445-456. (Pubitemid 37475653)
8. Clemmons DR (2009). Role of IGF-I in skeletal muscle mass maintenance. Trends Endocrinol Metab 20, 349-356.
9. Coolican SA, Samuel DS, Ewton DZ, McWade FJ, Florini JR (1997). The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 272, 6653-6662. (Pubitemid 27118151)
10. Cooper MA, Son AI, Komlos D, Sun Y, Kleiman NJ, Zhou R (2008). Loss of ephrin-A5 function disrupts lens fiber cell packing and leads to cataract. Proc Natl Acad Sci USA 105, 16620-16625.
11. de Alvaro C, Martinez N, Rojas JM, Lorenzo M (2005). Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2. Mol Biol Cell 16, 4454-4461. (Pubitemid 41262910)
12. Elowe S, Holland SJ, Kulkarni S, Pawson T (2001). Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol Cell Biol 21, 7429-7441. (Pubitemid 32953493)
13. Ewton DZ, Roof SL, Magri KA, McWade FJ, Florini JR (1994). IGF-II is more active than IGF-I in stimulating L6A1 myogenesis: greater mitogenic actions of IGF-I delay differentiation. J Cell Physiol 161, 277-284. (Pubitemid 24353556)
14. Florini JR, Ewton DZ, Coolican SA (1996). Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 17, 481-517. (Pubitemid 26346639)
15. Florini JR, Magri KA, Ewton DZ, James PL, Grindstaff K, Rotwein PS (1991). "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J Biol Chem 266, 15917-15923. (Pubitemid 21907745)
16. Fukuhara S, Sako K, Minami T, Noda K, Kim HZ, Kodama T, Shibuya M, Takakura N, Koh GY, Mochizuki N (2008). Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1. Nat Cell Biol 10, 513-526. (Pubitemid 351627371)
17. Fukuhara S, Sakurai A, Sano H, Yamagishi A, Somekawa S, Takakura N, Saito Y, Kangawa K, Mochizuki N (2005). Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25, 136-146. (Pubitemid 40039806)
18. Gavard J, Marthiens V, Monnet C, Lambert M, Mege RM (2004). N-cadherin activation substitutes for the cell contact control in cell cycle arrest and myogenic differentiation: involvement of p120 and beta-catenin. J Biol Chem 279, 36795-36802. (Pubitemid 39129028)
19. Guasconi V, Puri PL (2009). Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration. Trends Cell Biol 19, 286-294.
20. Gutierrez J, Brandan E (2010). A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation. Mol Cell Biol 30, 1634-1649.
21. Jun G et al. (2009). EPHA2 is associated with age-related cortical cataract in mice and humans. PLoSGenet 5, e1000584.
22. Kaliman P, Canicio J, Shepherd PR, Beeton CA, Testar X, Palacin M, Zorzano A (1998). Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol 12, 66-77. (Pubitemid 28124780)
23. Kaliman P, Vinals F, Testar X, Palacin M, Zorzano A (1996). Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem 271, 19146-19151. (Pubitemid 26271577)
24. Kang JS, Bae GU, Yi MJ, Yang YJ, Oh JE, Takaesu G, Zhou YT, Low BC, Krauss RS (2008). A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38alpha/beta MAPK activity and myogenic differentiation. J Cell Biol 182, 497-507.
25. Kang JS, Yi MJ, Zhang W, Feinleib JL, Cole F, Krauss RS (2004). Netrins and neogenin promote myotube formation. J Cell Biol 167, 493-504. (Pubitemid 39489057)
26. Kim I, Ryu YS, Kwak HJ, Ahn SY, Oh JL, Yancopoulos GD, Gale NW, Koh GY (2002). EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin-1-induced Ras/mitogen-activated protein kinase in venous endothelial cells. FASEB J 16, 1126-1128.
27. Koyama T et al. (2008). Interaction of scaffolding adaptor protein Gab1 with tyrosine phosphatase SHP2 negatively regulates IGF-I-dependent myogenic differentiation via the ERK1/2 signaling pathway. J Biol Chem 283, 24234-24244.
28. Krauss RS (2010). Regulation of promyogenic signal transduction by cell-cell contact and adhesion. Exp Cell Res 316, 3042-3049.
29. Lai KO, Chen Y, Po HM, Lok KC, Gong K, Ip NY (2004). Identification of the Jak/Stat proteins as novel downstream targets of EphA4 signaling in muscle: implications in the regulation of acetylcholinesterase expression. J Biol Chem 279, 13383-13392. (Pubitemid 38468861)
30. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A (1993). Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72. (Pubitemid 23306021)
31. Lovett FA, Gonzalez I, Salih DA, Cobb LJ, Tripathi G, Cosgrove RA, Murrell A, Kilshaw PJ, Pell JM (2006). Convergence of Igf2 expression and adhesion signalling via RhoA and p38 MAPK enhances myogenic differentiation. J Cell Sci 119, 4828-4840. (Pubitemid 46017796)
32. Lu M, Krauss RS (2010). N-cadherin ligation, but not Sonic hedgehog binding, initiates Cdo-dependent p38alpha/beta MAPK signaling in skeletal myoblasts. Proc Natl Acad Sci USA 107, 4212-4217.
33. Macrae M, Neve RM, Rodriguez-Viciana P, Haqq C, Yeh J, Chen C, Gray JW, McCormick F (2005). A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 8, 111-118. (Pubitemid 41132740)
34. Miao H, Nickel CH, Cantley LG, Bruggeman LA, Bennardo LN, Wang B (2003). EphA kinase activation regulates HGF-induced epithelial branching morphogenesis. J Cell Biol 162, 1281-1292. (Pubitemid 37210884)
35. Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E, Wang B (2001). Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 3, 527-530. (Pubitemid 32422092)
36. Miura K, Nam JM, Kojima C, Mochizuki N, Sabe H (2009). EphA2 engages Git1 to suppress Arf6 activity modulating epithelial cell-cell contacts. Mol Biol Cell 20, 1949-1959.
37. Noda K, Zhang J, Fukuhara S, Kunimoto S, Yoshimura M, Mochizuki N (2010). Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through α- and β-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells. Mol Biol Cell 21, 584-596.
38. Parri M, Buricchi F, Taddei ML, Giannoni E, Raugei G, Ramponi G, Chiarugi P (2005). EphrinA1 repulsive response is regulated by an EphA2 tyrosine phosphatase. J Biol Chem 280, 34008-34018. (Pubitemid 41443122)
39. Pasquale EB (2005). Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6, 462-475.
40. Pasquale EB (2008). Eph-ephrin bidirectional signaling in physiology and disease. Cell 133, 38-52.
41. Pasquale EB (2010). Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 10, 165-180.
42. Pavlath GK (2010). Spatial and functional restriction of regulatory molecules during mammalian myoblast fusion. Exp Cell Res 316, 3067-3072.
43. Shamah SM et al. (2001). EphA receptors regulate growth cone dynamics through the novel guanine nucleotide exchange factor ephexin. Cell 105, 233-244. (Pubitemid 32429513)
44. Swartz ME, Eberhart J, Pasquale EB, Krull CE (2001). EphA4/ephrin-A5 interactions in muscle precursor cell migration in the avian forelimb. Development 128, 4669-4680. (Pubitemid 33138578)
45. Taddei ML et al. (2009). Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Am J Pathol 174, 1492-1503.
46. Takaesu G, Kang JS, Bae GU, Yi MJ, Lee CM, Reddy EP, Krauss RS (2006). Activation of p38alpha/beta MAPK in myogenesis via binding of the scaffold protein JLP to the cell surface protein Cdo. J Cell Biol 175, 383-388. (Pubitemid 44708063)
47. Taylor MV (2002). Muscle differentiation: how two cells become one. Curr Biol 12, R224-R228.
48. Tong J, Elowe S, Nash P, Pawson T (2003). Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity. J Biol Chem 278, 6111-6119. (Pubitemid 36800863)
49. Tortorella LL, Milasincic DJ, Pilch PF (2001). Critical proliferation-independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J Biol Chem 276, 13709-13717.
50. White MF (2003). Insulin signaling in health and disease. Science 302, 1710-1711.
51. Yokoyama T, Takano K, Yoshida A, Katada F, Sun P, Takenawa T, Andoh T, Endo T (2007). DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation. J Cell Biol 177, 781-793. (Pubitemid 46873085)